Artelo Biosciences
ARTL
Artelo Biosciences (ARTL) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$151.47
- EPS estimate
- −$113.13
- EPS surprise
- −33.89%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 13, 2025 | −$113.13 | −$151.47 | −33.89% | $0.00 | SEC |
| Q1 2025 | May 13, 2025 | −$21.59 | −$116.64 | −440.14% | $0.00 | SEC |
| Q4 2024 | Mar 3, 2025 | −$70.74 | −$189.54 | −167.94% | $0.00 | SEC |
| Q3 2024 | Nov 12, 2024 | −$128.39 | −$56.70 | +55.84% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$128.52 | −$121.50 | +5.46% | $0.00 | SEC |
| Q1 2024 | May 13, 2024 | −$158.76 | −$126.36 | +20.41% | $0.00 | SEC |
| Q4 2023 | Mar 25, 2024 | −$90.18 | −$160.38 | −77.84% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$104.76 | −$134.46 | −28.35% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$125.55 | −$90.72 | +27.74% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$178.20 | −$123.12 | +30.91% | $0.00 | SEC |
| Q3 2022 | Nov 8, 2022 | −$143.10 | −$132.84 | +7.17% | $0.00 | — |
| Q2 2022 | Aug 9, 2022 | −$137.70 | −$140.94 | −2.35% | $0.00 | — |
| Q1 2022 | May 12, 2022 | −$133.65 | −$194.40 | −45.45% | $0.00 | — |
| Q3 2021 | Jul 12, 2021 | −$170.10 | −$243.00 | −42.86% | $0.00 | — |
| Q2 2021 | Apr 13, 2021 | −$279.45 | −$267.30 | +4.35% | $0.00 | — |
| Q1 2021 | Jan 14, 2021 | −$243.00 | −$340.20 | −40.00% | $0.00 | — |
| Q4 2020 | Nov 4, 2020 | −$874.80 | −$534.60 | +38.89% | $0.00 | — |
| Q3 2020 | Jul 13, 2020 | −$972.00 | −$656.10 | +32.50% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Artelo Biosciences (ARTL) last report earnings?
Artelo Biosciences last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did ARTL beat earnings estimates?
No. Artelo Biosciences reported EPS of −$151.47 for Q2 2025 against a −$113.13 estimate — a 33.89% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.